We are an immuno-oncology, hematology and non hematology (solid tumor) cancer drug development, clinical operations, strategic regulatory pathway of approval Support Company. We are focused on drug development, medical affairs, life cycle management and commercialization support to Pharma.
Our world-renowned team of oncologists and hematologists has the latest knowledge, expertise and experience of drug development and clinical trials. We offer specialized clinical operations support and excellence in medical oncology (breast cancer, gastrointestinal cancers, genitourinary cancers, lung and thoracic cancers, brain tumors, as well as other less common solid tumors), blood cancers (lymphoma, myeloma, acute and chronic leukemias, and myeloproliferative neoplasms), non-malignant hematology and vascular diseases, and bone marrow and stem cell transplantation worldwide.
We have group of physicians, clinical research investigators focused on basic and translational and late stage phase 1-3, 3b and 4 clinical research in hematology, vascular biology and oncology. Additionally, our company has been supporting several clinical trials, bringing some of the most innovative and novel approaches to cancer therapy out of the lab and directly to the patients.
To provide state-of-the-art, personalized clinical trial support, we have a talented and dedicated team of professionals. This includes a multidisciplinary investigator physicians, medical monitors, safety monitors, medical affairs, regulatory affairs, KoLs, Advisory Board Members, Project Directors, and highly enthusiastic clinical operations group at ClinfoMatrix.